Catalog No.
YVV42401
Expression system
E. coli
Species
Parainfluenza virus 5 (strain W3) (PIV5) (Simian virus 5)
Protein length
Met1-Ile509
Predicted molecular weight
58.70 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q88435
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Nucleoprotein, Nucleocapsid protein, NP, Protein N, NP, N
A region of mumps virus nucleoprotein affects defective interfering particle production., PMID:40214656
Paramyxovirus-Like Particles as Protein Delivery Vehicles., PMID:34379508
A Point Mutation in the RNA-Binding Domain of Human Parainfluenza Virus Type 2 Nucleoprotein Elicits Abnormally Enhanced Polymerase Activity., PMID:28179533
First complete genome sequence of parainfluenza virus 5 isolated from lesser panda., PMID:28138777
Human IFIT1 Inhibits mRNA Translation of Rubulaviruses but Not Other Members of the Paramyxoviridae Family., PMID:27512068
C-Terminal DxD-Containing Sequences within Paramyxovirus Nucleocapsid Proteins Determine Matrix Protein Compatibility and Can Direct Foreign Proteins into Budding Particles., PMID:26792745
Regulation of Viral RNA Synthesis by the V Protein of Parainfluenza Virus 5., PMID:26378167
Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection., PMID:25803697
Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses., PMID:23514880
Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge., PMID:23077314
Sumoylation of the P protein at K254 plays an important role in growth of parainfluenza virus 5., PMID:21795356
Identification of a phosphorylation site within the P protein important for mRNA transcription and growth of parainfluenza virus 5., PMID:21680523
The C-terminal end of parainfluenza virus 5 NP protein is important for virus-like particle production and M-NP protein interaction., PMID:20943976
A role for caveolin 1 in assembly and budding of the paramyxovirus parainfluenza virus 5., PMID:20631121
Parainfluenza virus 5 genomes are located in viral cytoplasmic bodies whilst the virus dismantles the interferon-induced antiviral state of cells., PMID:19458173
Human parainfluenza virus type 2 V protein inhibits genome replication by binding to the L protein: possible role in promoting viral fitness., PMID:18417591
For research use only. Not for human or drug use.
